BRCA1 / BRCA2

Berberine is a natural compound found in plants like goldenseal and barberry that has shown anti-cancer properties in laboratory and clinical studies.
Research suggests it may inhibit cancer cell growth, induce apoptosis, and enhance the effectiveness of chemotherapy.

Why BRCA1 / BRCA2 Is Being Studied for Cancer

  • Activates AMPK pathway, which regulates cell growth

  • May inhibit tumor cell proliferation in multiple cancer types

  • Shows potential to enhance chemotherapy effectiveness

  • Generally well-tolerated with low toxicity profile

Cancer Types Being Studied

  • Breast cancer

  • Colorectal cancer

  • Lung cancer

  • Pancreatic cancer

  • Liver cancer

Related Topics in Our Archive

  • Berberine and chemotherapy

  • Berberine AMPK pathway

  • Berberine dosage

  • Berberine side effects

Common Research Questions

  • What is the recommended dosage in cancer studies?

  • Does berberine interact with chemotherapy drugs?

  • Which cancer types have the most research

  • What are the potential side effects?

What Researchers Are Studying

  • Mechanisms of action (how it affects cancer cells)

  • Combination with standard treatments

  • Bioavailability and absorption

  • Safety profiles and dosing

Browse BRCA1 / BRCA2 Research

→ Search our archive for "BRCA1 or BRCA2"

Disclaimer

This page is for informational purposes only. Always consult your oncologist before adding any supplement to your treatment plan.